Diagnostics and management of herpes zoster ophthalmicus

被引：0
作者：
Werner R.N. [1 ,2 ]
Steinhorst N.-I. [3 ]
Nast A. [1 ]
Pleyer U. [3 ]
机构：
[1] Klinik für Dermatologie, Venerologie und Allergologie, Division of Evidence based Medicine (dEBM), Charité – Universitätsmedizin Berlin, Berlin
[2] MVZ Ärztezentrum Nollendorfplatz, Berlin
[3] Universitäts-Augenklinik, Uveitis Zentrum, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, Berlin
来源：
Spektrum der Augenheilkunde | 2018年 / 32卷 / 4-5期
关键词：
Acute retinal necrosis syndrome; Anterior uveitis; Complications; Guidelines; Shingles;
D O I：
10.1007/s00717-018-0408-7
中图分类号：
学科分类号：
摘要：
Herpes zoster (HZ, shingles) represents the secondary manifestation of an infection with varicellazoster virus (VZV). A reactivation of dormant VZV in the ophthalmic branch of the fifth cranial nerve leads to ophthalmic HZ (HZO). The predominantly older and immune compromised patients often present with eye involvement (approximately 50%) as well as characteristic skin changes. Clinical manifestations include the cornea and conjunctiva but anterior uveitis and (rarely) acute retinal necrosis may also occur. Associated sensory symptoms that range from paresthesia to severe pain may severely affect the quality of life. Particularly in immunocompromised and/or elderly patients, HZO is associated with complicated courses. Systemic antiviral treatment and an adequate pain medication are the mainstay of the recommended management. The present article provides an overview of the contents of the current consensus-based European guidelines on the management of HZ with a specific focus on HZO. © 2018, Springer-Verlag GmbH Austria, ein Teil von Springer Nature.
引用
收藏
页码：201 / 214
页数：13
相关论文
共 62 条
  • [1] Werner R.N., Nikkels A.F., Marinovic B., Et al., European consensus-based (S2k) Guideline on the Management of Herpes Zoster – guided by the European dermatology forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), part 1: diagnosis, J Eur Acad Dermatol Venereol, 31, pp. 9-19, (2017)
  • [2] Werner R.N., Nikkels A.F., Marinovi C.B., Et al., European consensus-based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment, J Eur Acad Dermatol Venereol, 31, pp. 20-29, (2017)
  • [3] The AGREE II Instrument, (2009)
  • [4] Cohen J.I., Herpes zoster, N Engl J Med, 369, pp. 255-263, (2013)
  • [5] Jones M., Dry I.R., Frampton D., Et al., RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation, Plos Pathog, 10, (2014)
  • [6] Zerboni L., Sen N., Oliver S., Molecular mechanisms of varicella zoster virus pathogenesis, Nat Rev Microbiol, 12, pp. 197-210, (2014)
  • [7] Hayward A.R., Herberger M., Lymphocyte responses to varicella zoster virus in the elderly, J Clin Immunol, 7, pp. 174-178, (1987)
  • [8] Moanna A., Rimland D., Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era, Clin Infect Dis, 57, pp. 122-125, (2013)
  • [9] Pinchinat S., Cebrian-Cuenca A.M., Bricout H., Johnson R.W., Similar herpes zoster incidence across Europe: results from a systematic literature review, BMC Infect. Dis., (2013)
  • [10] Yawn B.P., Gilden D., The global epidemiology of herpes zoster, Neurology, 81, pp. 928-930, (2013)
1234567